La Prensa MedicaISSN: 0032-745X

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Linda Shavit Author

shavit13244@gmail.com

Subjects of specialization
Rhabdoid melanoma; Parotid gland; Ipilumumab; Paclitaxelcarboplatin

Affiliation
Shaare Zedek Medical Center | szmc

Biography

Linda Shavit was working as an Assistant Professor in the Shaare Zedek Medical Center and he has research publications on A randomized multicenter trial on a lung ultrasound guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk

Publications

Research Article Subscription

Implantable Port-a-Cath System Insertion in Patients with Metastatic Colon Cancer Receiving Bevacizumab-Based Chemotherapy

Author(s):

Tal Grenader and Linda Shavit

 Implantable Port-a-Cath System Insertion in Patients with Metastatic Colon Cancer Receiving Bevacizumab-Based Chemotherapy

Combination of bevacizumab with continuous 5- fluoracil (5-FU)-based regimens are considered to be the backbone of colorectal cancer (CRC) systemic therapy. Administration of these continuous intravenous regimens requires insertion of an indwelling central venous catheters and implantable port systems. Certain aspects of the toxicity profile of Bevacizumab could interfere with implantable port-a-cath insertion. The aim of present study was to evaluate the safety port-a-cath insertion shortly before or during view more»

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP